Literature DB >> 15164229

Philadelphia (Ph) chromosome-positive thrombocythemia without features of chronic myeloid leukemia in peripheral blood: natural history and diagnostic differentiation from Ph-negative essential thrombocythemia.

Jan Jacques Michiels1, Zwi Berneman, Wilfried Schroyens, Jack Kutti, Birgitta Swolin, Börje Ridell, Pagani Fernando, Ulises Zanetto.   

Abstract

We have evaluated the clinical symptoms, hematological features, and natural history of 3 cases and 20 reported cases described as Philadelphia chromosome-positive (Ph+) essential thrombocythemia (ET). The presence of increased small mononuclear megakaryocytes in bone marrow smears and biopsy material in patients with pronounced thrombocytosis and no evidence of chronic myeloid leukemia (CML) in peripheral blood appeared to be a diagnostic clue to the diagnosis of Ph+ (essential) thrombocythemia. As compared to cases of reactive thrombocytosis, the megakaryocytes in Ph+ thrombocythemia are smaller than normal ones and typically have hypolobulated round nuclei. This contrasts with the finding of clustered mature and enlarged megakaryocytes in Ph-negative true ET. Patients diagnosed as Ph+ ET may progress to CML and show a high tendency to myelofibrosis and blastic transformation. These observations indicate that both Ph+ ET and Ph+ thrombocythemia associated with CML can be regarded as early manifestations of the chronic stable phase of CML. Copyright 2004 Springer-Verlag

Entities:  

Mesh:

Year:  2004        PMID: 15164229     DOI: 10.1007/s00277-004-0877-4

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  6 in total

1.  A case of chronic myeloid leukemia with features of essential thrombocythemia in peripheral blood and bone marrow.

Authors:  Young Jae Byun; Byeong-Bae Park; Eun Sung Lee; Kyung Soo Choi; Dae Sung Lee
Journal:  Blood Res       Date:  2014-06-25

2.  Chronic myeloid leukaemia with extreme thrombocytosis.

Authors:  Shailendra Prasad Verma; Arunkumar Subbiah; Sajini Elizabeth Jacob; Debdatta Basu
Journal:  BMJ Case Rep       Date:  2015-08-19

Review 3.  Essential thrombocythemia.

Authors:  Jean B Brière
Journal:  Orphanet J Rare Dis       Date:  2007-01-08       Impact factor: 4.123

Review 4.  Clinical Features and Outcomes of Patients With Chronic Myeloid Leukemia Presenting With Isolated Thrombocytosis: A Systematic Review and a Case From Our Institution.

Authors:  Dawood Findakly; Waqas Arslan
Journal:  Cureus       Date:  2020-06-23

Review 5.  Personalized management of essential thrombocythemia-application of recent evidence to clinical practice.

Authors:  A Tefferi; T Barbui
Journal:  Leukemia       Date:  2013-04-05       Impact factor: 11.528

6.  Analysis of clinical characteristics and efficacy of chronic myeloid leukemia onset with extreme thrombocytosis in the era of tyrosine kinase inhibitors.

Authors:  Zhihe Liu; Hongqiong Fan; Yuying Li; Chunshui Liu
Journal:  Onco Targets Ther       Date:  2017-07-17       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.